represented pregnancies with PAS who delivered by cesarean-hysterectomy and had a first trimester ultrasound with LGSI. Controls represented pregnancies with persistent placenta previas without PAS, who delivered by cesarean-section without post-partum hemorrhage and had a first trimester ultrasound with LGSI. Sonographic images were reviewed by an investigator blinded to pregnancy outcome and sonography reports. Images were reviewed for presence of abnormal utero-placental interface, increased uterovesical hypervascularity, and placental lacunae, with or without swirling on gray scale or color Doppler. Definitions of ultrasound markers followed national task force on PAS. RESULTS: 21 cases and 46 controls met the inclusion criteria. Lacunae were present in 18/21 (85.7%) cases and in 7/46 (15.2%) controls (OR 33.4; 95% CI 7.7-144.4, p<.001). Presence of 3 or more lacunae were 100% predictive of PAS with an average of 5.0 lacunae in cases compared to 1.3 in controls (p¼.019). The average size of the lacunae was 9.88AE3.7mm in cases and 4.41AE0.56 mm in controls (p<.001). Lacunae swirling on gray scale or color Doppler were 100% predictive of PAS (p<.001). Presence of an abnormal uteroplacental interface was also 100% predictive of PAS (p<.001). Uterovesical hypervascularity was present in 14/14 cases and only 1/12 controls (p<.001). CONCLUSION: To our knowledge this is the first study evaluating the predictive value of PAS markers in early gestation in pregnancies with LGSI. In pregnancies with LGSI, presence of 3 or more lacunae or abnormal utero-placental interface in the first trimester is highly predictive of PAS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.